Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2013
10/01/2013US8546407 Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
10/01/2013US8546406 Heterocyclic compounds as metap-2 inhibitors
10/01/2013US8546405 Anti-viral compounds
10/01/2013US8546398 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/01/2013US8546395 6-cycloamino-3-(1H-pyrrolo[2,3-b]pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
10/01/2013US8546393 6-triazolopyridazine sulfanyl benzothiazole derivatives as MET inhibitors
10/01/2013US8546383 Chiral fused [1,2]imidazo[4,5-c] ring compounds
10/01/2013US8546379 5HT2C receptor modulators
10/01/2013US8546374 Amino-tetrazoles analogues and methods of use
10/01/2013US8546291 Cyclic compound, its metal complex and modified metal complex
10/01/2013CA2776407C Method of preparing sitagliptin and intermediates used therein
10/01/2013CA2719876C Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/01/2013CA2710959C Imidazole carbonyl compounds and use thereof for treating bacterial infections
10/01/2013CA2612726C Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates
09/2013
09/26/2013WO2013142307A1 Carbamate compounds and of making and using same
09/26/2013WO2013142269A1 Imidazotriazinone compounds
09/26/2013WO2013140347A1 Sulphonamide derivatives of benzylamine for the treatment of cns diseases
09/26/2013WO2013140189A1 6- (4- (1 -amino- 3 -hydroxycyclobutyl) phenyl) - 5 - phenyl (furo, thieno or pyrrolo) [2, 3-d] pyrimidin- 4 - one derivatives for the treatment of cancer
09/26/2013WO2013139929A1 Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
09/26/2013WO2012159565A9 6-(aryl-carboxamide) imidazo [1,2-a] pyrimidine and 6-(aryl carboxamide) [1,2,4] triazolo [4,3-a] pyrimidine as hedgehog pathway inhibitor and use thereof
09/26/2013US20130253194 PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
09/26/2013US20130253193 Processes for preparing jak inhibitors and related intermediate compounds
09/26/2013US20130253191 Processes for preparing jak inhibitors and related intermediate compounds
09/26/2013US20130253190 Processes for preparing jak inhibitors and related intermediate compounds
09/26/2013US20130253186 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
09/26/2013US20130252951 7-hydroxy-pyrazolo[1,5-a] pyrimidine compounds and their use as ccr2 receptor antagonists
09/26/2013US20130252936 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
09/26/2013US20130252885 Fused tricyclic compounds as adenosine receptor antagonist
09/25/2013EP2641907A1 Preparation of modulators of 5-HT receptors
09/25/2013EP2640726A1 Novel compound for organic electronic material and organic electroluminescent device using the same
09/25/2013EP2640725A1 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
09/25/2013EP2640723A1 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
09/25/2013EP2640722A1 Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
09/25/2013EP2640705A2 Novel antiviral compounds
09/25/2013EP2640392A2 Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
09/25/2013CN103329623A Broadly absorbing metalloporphyrin-based multichromophoric arrays for triplet harvesting
09/25/2013CN103329299A Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
09/25/2013CN103328482A New bicyclic compound for modulating G protein-coupled receptors
09/25/2013CN103328479A 7-hydroxy-pyrazolo[1,5-A] pyrimidine compounds and their use as CCR2 receptor antagonists
09/25/2013CN103328472A Imidazopyridines as respiratory syncytial virus antiviral agents
09/25/2013CN103319492A Method for preparing metallic perfluorophthalocyanine derivative
09/25/2013CN103319491A Synthesis method of dimethyl substituted glucoside urea dipolymer
09/25/2013CN103319490A Hole injection material for organic light-emitting device, as well as preparation method and application thereof
09/25/2013CN103319489A Triazolopyrimidine sulfonamide compound, and synthetic method and application thereof
09/25/2013CN103319488A Inhibitors of bruton's tyrosine kinase
09/25/2013CN103319487A Preparation method of sitagliptin and intermediate of sitagliptin
09/25/2013CN103319486A Method for synthesis of 4H-imidazo[1, 5-a][1, 4]benzodiazepine, especially midazolam
09/25/2013CN103319468A Substituted spirobicyclic compounds, and application method and applications thereof
09/25/2013CN103319464A 病毒聚合酶抑制剂 Viral polymerase inhibitors
09/25/2013CN101932582B Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
09/25/2013CN101868461B Process for the synthesis of E1 activating enzyme inhibitors
09/25/2013CN101696208B Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
09/25/2013CN101547924B Compounds for inhibiting mitotic progression
09/24/2013US8541595 Imidazoisoindole neuropeptide S receptor antagonists
09/24/2013US8541576 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
09/24/2013US8541447 3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof
09/24/2013US8541445 Pyrazolopyridines
09/24/2013US8541438 Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
09/24/2013US8541432 Heterobicyclic carboxamides as inhibitors for kinases
09/24/2013US8541429 Pyrazolo quinazoline derivatives, process for their preparation and their use as kinase inhibitors
09/24/2013US8541427 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use
09/24/2013US8541425 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
09/24/2013US8541407 Substituted benzo-pyrido-triazolo-diazepine compounds
09/24/2013CA2632466C Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
09/19/2013WO2013138612A1 Synthesis and application of novel imaging agents conjugated to dpa 713 analogs for imaging inflammation
09/19/2013WO2013138568A1 Liver x reception modulators
09/19/2013WO2013138565A1 Liver x receptor modulators
09/19/2013WO2013138418A2 Process for making cgrp receptor antagonists
09/19/2013WO2013137001A1 Organic electroluminescent element
09/19/2013WO2013136076A1 Crystalline pi3 kinase inhibitors
09/19/2013WO2013136075A1 Novel pharmaceutical formulations
09/19/2013WO2013135671A1 Fungicidal pyrimidine compounds
09/19/2013WO2013135612A1 Substituted imidazopyridazines
09/19/2013WO2013102929A4 Novel compounds for treatment of diabetes, obesity or related disorders
09/19/2013WO2013028818A8 Pyrimido- pyridazinone compounds and use thereof
09/19/2013US20130245260 Neprilysin inhibitors
09/19/2013US20130245254 Methods of synthesis and purification of heteroaryl compounds
09/19/2013US20130245049 Novel Antiviral Compounds
09/19/2013US20130245045 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes
09/19/2013US20130245044 Triazolo[4, 5-d] pyramidine derivatives and their use as purine receptor antagonists
09/19/2013US20130245043 Substituted imidazopyrimidin-5(6h)-ones as allosteric modulators of mglur5 receptors
09/19/2013US20130245032 Bicyclic and tricyclic inhibitors of sumoylation enzymes and methods of their use
09/19/2013US20130245031 Fused heteroaromatic pyrrolidinones
09/19/2013US20130245028 Treatment of cancer with tor kinase inhibitors
09/19/2013US20130245023 6-CYCLOAMINO-3-(PYRIDAZIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE AND DERIVATIVES THEREOF PREPARATION AND THERAPEUTIC APPLICATION THEREOF
09/19/2013US20130245022 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
09/19/2013US20130245021 IMIDAZO[1,2-b]PYRIDAZINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
09/19/2013US20130245013 Storage stable perfusion solution for dihydropteridinones
09/19/2013US20130245001 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/19/2013US20130244999 Substituted Heterocyclic Compounds
09/19/2013US20130244994 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
09/19/2013US20130244966 Fatty acid antiviral conjugates and their uses
09/19/2013DE102012204327A1 Optoelektronisches Bauelement und Verfahren zum Herstellen eines optoelektronischen Bauelements Optoelectronic component and method of manufacturing an optoelectronic component
09/18/2013EP2638046A2 Spiro-oxindole mdm2 antagonists
09/18/2013EP2638045A1 Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
09/18/2013EP2638044A1 Alkoxy-substituted 2,3-dihydroimidazo[1,2-c]quinazolines
09/18/2013EP2638043A1 Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-c]quinolines
09/18/2013EP2637669A2 Heterocyclic compounds and uses thereof
09/18/2013EP2637656A1 Piperidinone carboxamide indane cgrp receptor antagonists
09/18/2013CN103313989A Tricyclic PI3K inhibitor compounds and methods of use
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 573